CHEN, RUSI
CHEN, RUSI
Borsisti
HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients
2026 Indre, Madalina-Gabriela; Stefanini, Bernardo; Boe, Maria; Capelli, Roberta; Chen, Rusi; Abbati, Chiara; Santangeli, Ernestina; Salamone, Agnese; Girolami, Francesca; Tovoli, Francesco; Morelli, Maria Cristina; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico
Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials
2026 Ascari, S.; Chen, R.; De Sinno, A.; Stefanini, B.; Cescon, M.; Serenari, M.; Mosconi, C.; Tovoli, F.
Advancements in immunotherapy for hepatocellular carcinoma
2025 Ascari, S.; Chen, R.; Vivaldi, C.; Stefanini, B.; De Sinno, A.; Dalbeni, A.; Federico, P.; Tovoli, F.
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab
2025 Stefanini, B.; Piscaglia, F.; Marra, F.; Iavarone, M.; Vivaldi, C.; Cabibbo, G.; Palloni, A.; Pressiani, T.; Dalbeni, A.; Stefanini, B.; Stella, L.; Federico, P.; Svegliati-Baroni, G.; Lonardi, S.; Solda, C.; Ielasi, L.; De Lorenzo, S.; Garajova, I.; Campani, C.; Bruccoleri, M.; Masi, G.; Celsa, C.; Brandi, G.; Auriemma, A.; Daniele, B.; Ponziani, F. R.; Lani, L.; Chen, R.; Boe, M.; Granito, A.; Rimassa, L.; Tovoli, F.; Ravaioli, F.; Franceschini, E.; Ascari, S.; Perna, A.; Vicardi, M.; Natola, L. A.; Filice, A.; Cattazzo, F.; Scorzoni, C.; Scandali, G.; Cerrito, L.; Santopaolo, F.; Pallozzi, M.; Pompili, M.; Gasbarrini, A.; Quartararo, A.; Calascibetta, S.
Liver stiffness measurement by SuperSonic Imagine two-dimensional shear wave elastography to predict hepatocellular carcinoma in non-cirrhotic metabolic dysfunction-associated steatotic liver disease
2025 Indre, MADALINA-GABRIELA; Stefanini, B.; Abbati, C.; Boe, M.; Cappelli, Roberta; Chen, R.; Santangeli, E.; Tovoli, F.; Morelli, M. C.; Piscaglia, F.; Ferri, S.; Ravaioli, F.
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?
2025 Chen, R.; Salamone, A.; Abbati, C.; Capelli, R.; Santangeli, E.; Stefanini, B.; Indre, MADALINA-GABRIELA; Ravaioli, F.; Piscaglia, F.; Ferri, S.
THU-401 Liver stiffness and MACE development: an intricate relationship
2025 Santangeli, Ernestina; Salamone, Agnese; Indre, MADALINA-GABRIELA; Boe, Maria; Capelli, Roberta; Stefanini, Bernardo; Chen, Rusi; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico
THU-402-YI Real-world practice using liver stiffness measurement through two-dimensional shear wave elastography (SuperSonic Imagine) as a predictive tool for hepatocellular carcinoma risk in noncirrhotic MASLD patients
2025 Indre, Madalina Gabriela; Stefanini, Bernardo; Salamone, Agnese; Abbati, Chiara; Boe, Maria; Capelli, Roberta; Chen, Rusi; Santangeli, Ernestina; Tovoli, Francesco; Morelli, Maria Cristina; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico
TOP-108-YI Prevalence and impact of clinically significant portal hypertension (CSPH) in patients with hepatocellular carcinoma (HCC): a multicenter cohort study on the ITA.LI.CA database
2025 Chen, Rusi; Rimondini, Matteo Dibetto; Giannini, Edoardo Giovanni; Santi, Valentina; Pelizzaro, Filippo; Sangiovanni, Angelo; Cabibbo, Giuseppe; Marra, Fabio; Foschi, Francesco; Svegliati-Baroni, Gianluca; Ponziani, Francesca Romana; Missale, Gabriele; Morisco, Filomena; Sacco, Rodolfo; Ghittoni, Giorgia; Saitta, Carlo; Vidili, Gianpaolo; Azzaroli, Francesco; Brunetto, Maurizia; Boninsegna, Sara; Sacerdoti, David; Nardone, Gerardo; Magalotti, Donatella; Mega, Andrea; Martini, Andrea; Tovoli, Francesco; Piscaglia, Fabio
Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma
2024 Chen, R.; Monaco, G.; Stefanini, B.; Marseglia, M.; De Lorenzo, S.; Tovoli, F.
Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review
2024 Santangeli, Ernestina; Abbati, Chiara; Chen, Rusi; Di Carlo, Alma; Leoni, Simona; Piscaglia, Fabio; Ferri, Silvia
Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib
2024 Stefanini, Bernardo; Tovoli, Francesco; Trevisani, Franco; Marseglia, Mariarosaria; Di Costanzo, Giovan Giuseppe; Cabibbo, Giuseppe; Sacco, Rodolfo; Pellizzaro, Filippo; Pressiani, Tiziana; Chen, Rusi; Ponziani, Francesca Romana; Foschi, Francesco Giuseppe; Magini, Giulia; Granito, Alessandro; Piscaglia, Fabio
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
2024 Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Palloni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio
Donafenib in hepatocellular carcinoma
2023 Chen R.; Ielasi L.; di Carlo A.; Tovoli F.
TKIs in combination with immunotherapy for hepatocellular carcinoma
2023 Stefanini B.; Ielasi L.; Chen R.; Abbati C.; Tonnini M.; Tovoli F.; Granito A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| HCC Is the Predominant Liver-Related Event in MASLD: 2-Step Non-Invasive Algorithms to Stratify Risk in Non-Cirrhotic Patients | Indre, Madalina-Gabriela; Stefanini, Bernardo; Boe, Maria; Capelli, Roberta; Chen, Rusi; Abbati, ...Chiara; Santangeli, Ernestina; Salamone, Agnese; Girolami, Francesca; Tovoli, Francesco; Morelli, Maria Cristina; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico | 2026-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | JHC-561956-hcc-is-the-predominant-liver-related-event-in-masld--2-step-.pdf |
| Post-immunotherapy second-line strategies for hepatocellular carcinoma: State of the art and ongoing trials | Ascari, S.; Chen, R.; De Sinno, A.; Stefanini, B.; Cescon, M.; Serenari, M.; Mosconi, C.; Tovoli, F. | 2026-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | WJG-32-111528.pdf |
| Advancements in immunotherapy for hepatocellular carcinoma | Ascari, S.; Chen, R.; Vivaldi, C.; Stefanini, B.; De Sinno, A.; Dalbeni, A.; Federico, P.; Tovoli..., F. | 2025-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | Advancements in Immunotherapy for Hepatocellular CarcinomaR1_BLANK.pdf |
| Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab | Stefanini, B.; Piscaglia, F.; Marra, F.; Iavarone, M.; Vivaldi, C.; Cabibbo, G.; Palloni, A.; Pre...ssiani, T.; Dalbeni, A.; Stefanini, B.; Stella, L.; Federico, P.; Svegliati-Baroni, G.; Lonardi, S.; Solda, C.; Ielasi, L.; De Lorenzo, S.; Garajova, I.; Campani, C.; Bruccoleri, M.; Masi, G.; Celsa, C.; Brandi, G.; Auriemma, A.; Daniele, B.; Ponziani, F. R.; Lani, L.; Chen, R.; Boe, M.; Granito, A.; Rimassa, L.; Tovoli, F.; Ravaioli, F.; Franceschini, E.; Ascari, S.; Perna, A.; Vicardi, M.; Natola, L. A.; Filice, A.; Cattazzo, F.; Scorzoni, C.; Scandali, G.; Cerrito, L.; Santopaolo, F.; Pallozzi, M.; Pompili, M.; Gasbarrini, A.; Quartararo, A.; Calascibetta, S. | 2025-01-01 | LIVER CANCER | - | 1.01 Articolo in rivista | 000545494.pdf; 29143535.zip |
| Liver stiffness measurement by SuperSonic Imagine two-dimensional shear wave elastography to predict hepatocellular carcinoma in non-cirrhotic metabolic dysfunction-associated steatotic liver disease | Indre, MADALINA-GABRIELA; Stefanini, B.; Abbati, C.; Boe, M.; Cappelli, Roberta; Chen, R.; Santan...geli, E.; Tovoli, F.; Morelli, M. C.; Piscaglia, F.; Ferri, S.; Ravaioli, F. | 2025-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause? | Chen, R.; Salamone, A.; Abbati, C.; Capelli, R.; Santangeli, E.; Stefanini, B.; Indre, MADALINA-G...ABRIELA; Ravaioli, F.; Piscaglia, F.; Ferri, S. | 2025-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| THU-401 Liver stiffness and MACE development: an intricate relationship | Santangeli, Ernestina; Salamone, Agnese; Indre, MADALINA-GABRIELA; Boe, Maria; Capelli, Roberta; ...Stefanini, Bernardo; Chen, Rusi; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico | 2025-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| THU-402-YI Real-world practice using liver stiffness measurement through two-dimensional shear wave elastography (SuperSonic Imagine) as a predictive tool for hepatocellular carcinoma risk in noncirrhotic MASLD patients | Indre, Madalina Gabriela; Stefanini, Bernardo; Salamone, Agnese; Abbati, Chiara; Boe, Maria; Cape...lli, Roberta; Chen, Rusi; Santangeli, Ernestina; Tovoli, Francesco; Morelli, Maria Cristina; Piscaglia, Fabio; Ferri, Silvia; Ravaioli, Federico | 2025-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| TOP-108-YI Prevalence and impact of clinically significant portal hypertension (CSPH) in patients with hepatocellular carcinoma (HCC): a multicenter cohort study on the ITA.LI.CA database | Chen, Rusi; Rimondini, Matteo Dibetto; Giannini, Edoardo Giovanni; Santi, Valentina; Pelizzaro, F...ilippo; Sangiovanni, Angelo; Cabibbo, Giuseppe; Marra, Fabio; Foschi, Francesco; Svegliati-Baroni, Gianluca; Ponziani, Francesca Romana; Missale, Gabriele; Morisco, Filomena; Sacco, Rodolfo; Ghittoni, Giorgia; Saitta, Carlo; Vidili, Gianpaolo; Azzaroli, Francesco; Brunetto, Maurizia; Boninsegna, Sara; Sacerdoti, David; Nardone, Gerardo; Magalotti, Donatella; Mega, Andrea; Martini, Andrea; Tovoli, Francesco; Piscaglia, Fabio | 2025-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Combination makes strength: a narrative review of transarterial radioembolization plus immune checkpoint inhibitors for hepatocellular carcinoma | Chen, R.; Monaco, G.; Stefanini, B.; Marseglia, M.; De Lorenzo, S.; Tovoli, F. | 2024-01-01 | CHINESE CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | cco-13-05-71.pdf |
| Pathophysiological-Based Nutritional Interventions in Cirrhotic Patients with Sarcopenic Obesity: A State-of-the-Art Narrative Review | Santangeli, Ernestina; Abbati, Chiara; Chen, Rusi; Di Carlo, Alma; Leoni, Simona; Piscaglia, Fabi...o; Ferri, Silvia | 2024-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | nutrients-16-00427.pdf |
| Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib | Stefanini, Bernardo; Tovoli, Francesco; Trevisani, Franco; Marseglia, Mariarosaria; Di Costanzo, ...Giovan Giuseppe; Cabibbo, Giuseppe; Sacco, Rodolfo; Pellizzaro, Filippo; Pressiani, Tiziana; Chen, Rusi; Ponziani, Francesca Romana; Foschi, Francesco Giuseppe; Magini, Giulia; Granito, Alessandro; Piscaglia, Fabio | 2024-01-01 | INTERNAL AND EMERGENCY MEDICINE | - | 1.01 Articolo in rivista | s11739-024-03578-8 (1).pdf; 11739_2024_3578_MOESM1_ESM.zip |
| Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma | Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Pal...loni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio | 2024-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | PIIS1590865824009198.pdf; 1-s2.0-S1590865824009198-mmc1.docx |
| Donafenib in hepatocellular carcinoma | Chen R.; Ielasi L.; di Carlo A.; Tovoli F. | 2023-01-01 | DRUGS OF TODAY | - | 1.01 Articolo in rivista | - |
| TKIs in combination with immunotherapy for hepatocellular carcinoma | Stefanini B.; Ielasi L.; Chen R.; Abbati C.; Tonnini M.; Tovoli F.; Granito A. | 2023-01-01 | EXPERT REVIEW OF ANTICANCER THERAPY | - | 1.01 Articolo in rivista | - |